[ad_1]
Avinger (NASDAQ:AVGR) and Mazor Robotics (NASDAQ:MZOR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations.
Institutional and Insider Ownership
10.1% of Avinger shares are held by institutional investors. Comparatively, 32.7% of Mazor Robotics shares are held by institutional investors. 1.5% of Avinger shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Profitability
This table compares Avinger and Mazor Robotics’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Avinger | -416.08% | N/A | -158.54% |
Mazor Robotics | -37.29% | -7.70% | -6.64% |
Earnings and Valuation
This table compares Avinger and Mazor Robotics’ gross revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Avinger | $9.93 million | 1.37 | -$48.73 million | ($70.07) | -0.01 |
Mazor Robotics | $64.95 million | 23.61 | -$12.41 million | ($0.50) | -116.46 |
Mazor Robotics has higher revenue and earnings than Avinger. Mazor Robotics is trading at a lower price-to-earnings ratio than Avinger, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Avinger has a beta of 1.65, meaning that its stock price is 65% more volatile than the S&P 500. Comparatively, Mazor Robotics has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500.
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Avinger and Mazor Robotics, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Avinger | 0 | 0 | 1 | 0 | 3.00 |
Mazor Robotics | 0 | 3 | 0 | 0 | 2.00 |
Mazor Robotics has a consensus target price of $59.50, suggesting a potential upside of 2.18%. Given Mazor Robotics’ higher possible upside, analysts clearly believe Mazor Robotics is more favorable than Avinger.
Summary
Mazor Robotics beats Avinger on 8 of the 14 factors compared between the two stocks.
About Avinger
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company’s lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat, and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company sells and markets its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.
About Mazor Robotics
Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. It operates in the field of computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness and that simplifies complex surgical procedures. The company’s surgical robotic-guidance systems and complementary products are used to conduct spine and brain procedures in an accurate and secure manner. It also offers Mazor X, a renaissance system and its accessories are used in spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision, and cement augmentations. The company was formerly known as Mazor Surgical Technologies Ltd. and changed its name to Mazor Robotics Ltd. in 2010. Mazor Robotics Ltd. was founded in 2000 and is based in Caesarea, Israel.
Receive News & Ratings for Avinger Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Avinger and related companies with MarketBeat.com’s FREE daily email newsletter.
[ad_2]
Source link
Leave A Comment
You must be logged in to post a comment.